Stryker Co. (NYSE:SYK) Position Increased by Capital Investment Services of America Inc.

Capital Investment Services of America Inc. raised its holdings in shares of Stryker Co. (NYSE:SYK) by 0.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 76,684 shares of the medical technology company’s stock after purchasing an additional 253 shares during the period. Stryker comprises about 2.9% of Capital Investment Services of America Inc.’s portfolio, making the stock its 11th largest holding. Capital Investment Services of America Inc.’s holdings in Stryker were worth $28,546,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of SYK. Norges Bank acquired a new stake in shares of Stryker in the 4th quarter worth about $1,710,744,000. GAMMA Investing LLC grew its position in Stryker by 43,226.8% in the 1st quarter. GAMMA Investing LLC now owns 2,074,922 shares of the medical technology company’s stock valued at $772,390,000 after buying an additional 2,070,133 shares in the last quarter. Raymond James Financial Inc. bought a new position in Stryker in the 4th quarter valued at about $353,394,000. FMR LLC grew its position in Stryker by 10.0% in the 4th quarter. FMR LLC now owns 8,034,844 shares of the medical technology company’s stock valued at $2,892,946,000 after buying an additional 727,850 shares in the last quarter. Finally, Proficio Capital Partners LLC grew its position in Stryker by 52,520.8% in the 4th quarter. Proficio Capital Partners LLC now owns 596,194 shares of the medical technology company’s stock valued at $214,660,000 after buying an additional 595,061 shares in the last quarter. Institutional investors and hedge funds own 77.09% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on SYK shares. Roth Mkm increased their target price on shares of Stryker from $405.00 to $456.00 and gave the company a “buy” rating in a research report on Friday, May 2nd. Wall Street Zen raised shares of Stryker from a “hold” rating to a “buy” rating in a report on Saturday. JMP Securities reissued a “market perform” rating on shares of Stryker in a report on Monday, May 5th. The Goldman Sachs Group set a $422.00 price target on shares of Stryker in a report on Tuesday, March 4th. Finally, BTIG Research set a $403.00 price target on shares of Stryker and gave the company a “buy” rating in a report on Monday, April 14th. Four analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $427.30.

Insider Transactions at Stryker

In other news, Director Ronda E. Stryker sold 200,000 shares of the firm’s stock in a transaction on Tuesday, May 6th. The shares were sold at an average price of $376.96, for a total value of $75,392,000.00. Following the sale, the director now owns 3,417,326 shares in the company, valued at approximately $1,288,195,208.96. This trade represents a 5.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 5.90% of the stock is currently owned by corporate insiders.

Stryker Trading Down 0.9%

NYSE:SYK opened at $377.01 on Friday. Stryker Co. has a 52 week low of $314.93 and a 52 week high of $406.19. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.32 and a current ratio of 1.95. The stock’s 50 day moving average price is $372.73 and its 200 day moving average price is $375.83. The company has a market capitalization of $143.90 billion, a P/E ratio of 48.58, a P/E/G ratio of 2.93 and a beta of 0.91.

Stryker (NYSE:SYK) last announced its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.84 EPS for the quarter, beating the consensus estimate of $2.73 by $0.11. Stryker had a return on equity of 23.58% and a net margin of 13.25%. The company had revenue of $5.87 billion for the quarter, compared to the consensus estimate of $5.68 billion. During the same quarter last year, the company posted $2.50 earnings per share. The company’s revenue for the quarter was up 11.9% compared to the same quarter last year. On average, research analysts forecast that Stryker Co. will post 13.47 EPS for the current fiscal year.

Stryker Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, July 31st. Shareholders of record on Monday, June 30th will be issued a dividend of $0.84 per share. The ex-dividend date of this dividend is Monday, June 30th. This represents a $3.36 annualized dividend and a yield of 0.89%. Stryker’s dividend payout ratio (DPR) is presently 45.41%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.